Abstract |
|
Authors | Joseph A Francisco, Charles G Cerveny, Damon L Meyer, Bruce J Mixan, Kerry Klussman, Dana F Chace, Starr X Rejniak, Kristine A Gordon, Ron DeBlanc, Brian E Toki, Che-Leung Law, Svetlana O Doronina, Clay B Siegall, Peter D Senter, Alan F Wahl |
Journal | Blood
(Blood)
Vol. 102
Issue 4
Pg. 1458-65
(Aug 15 2003)
ISSN: 0006-4971 [Print] United States |
PMID | 12714494
(Publication Type: Journal Article)
|
Chemical References |
- Antibodies, Monoclonal
- Antineoplastic Agents
- Immunoconjugates
- Immunotoxins
- Ki-1 Antigen
- Oligopeptides
- Brentuximab Vedotin
|
Topics |
- Animals
- Antibodies, Monoclonal
(adverse effects, chemistry, pharmacology)
- Antineoplastic Agents
(adverse effects, chemistry, pharmacology)
- Apoptosis
(drug effects)
- Brentuximab Vedotin
- Cell Cycle
(drug effects)
- Drug Stability
- Hodgkin Disease
(drug therapy, immunology, metabolism)
- Humans
- Immunoconjugates
(chemistry, pharmacology)
- Immunotoxins
(chemistry, pharmacology)
- Inhibitory Concentration 50
- Ki-1 Antigen
(immunology, metabolism)
- Mice
- Mice, SCID
- Oligopeptides
(adverse effects, chemistry, pharmacology)
- Tumor Cells, Cultured
- Xenograft Model Antitumor Assays
|